Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

DIAGNOSTIC PATHOLOGY MEDICAL GROUP, INC

UEI: TG4MKMNWB4Q5CAGE: 7LCB4

DIAGNOSTIC PATHOLOGY MEDICAL GROUP, INC is a federal contractor, registered under UEI TG4MKMNWB4Q5 and CAGE code 7LCB4. It has been awarded $1,570,770 in federal contracts. Primary work spans Medical Laboratories. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

TG4MKMNWB4Q5

CAGE Code

7LCB4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Diagnostic Pathology Medical Group, Inc. specializes in histopathology services, providing expert diagnostic analysis of tissue samples to support clinical decision-making for veteran healthcare systems. The contractor delivers comprehensive anatomic pathology solutions, including slide preparation,...

Diagnostic Pathology Medical Group, Inc. specializes in histopathology services, providing expert diagnostic analysis of tissue samples to support clinical decision-making for veteran healthcare systems. The contractor delivers comprehensive anatomic pathology solutions, including slide preparation, microscopic evaluation, immunohistochemical staining, and diagnostic reporting, all aligned with CAP and CLIA standards. Their technical expertise centers on accurate tumor characterization, surgical pathology interpretation, and rapid turnaround of complex histologic cases, ensuring timely patient care within VA medical facilities. A key differentiator is their focused delivery of high-volume, high-accuracy histopathology services tailored to the operational needs of large-scale federal healthcare networks, with consistent performance across multiple geographic regions within Northern California. The contractor maintains a sustained, long-term relationship with the Department of Veterans Affairs, consistently providing histopathology services to the VA Northern California Healthcare System and other VA medical centers. Their work supports critical oncology, surgical, and diagnostic workflows, enabling VA providers to deliver precise, evidence-based care to veteran populations. The recurring nature of these engagements reflects a trusted, reliable partnership built on adherence to federal healthcare protocols and consistent service quality. The primary industry focus is Medical Laboratories (NAICS 621511), where the contractor operates as a specialized anatomic pathology provider within the federal healthcare supply chain. They occupy a niche position serving government-funded institutions requiring accredited, high-throughput diagnostic services, particularly in surgical and oncologic pathology. As a 2L entity based in Sacramento, California, Diagnostic Pathology Medical Group, Inc. operates as a regional provider with deep integration into VA healthcare delivery networks. The company holds no federal certifications but maintains operational compliance with clinical laboratory quality standards required for federal contract performance.

Key Performance Metrics

Awards Count

11

All time

Active

1

Currently performing

Completed

10

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with DIAGNOSTIC PATHOLOGY MEDICAL GROUP, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DIAGNOSTIC PATHOLOGY MEDICAL GROUP, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DIAGNOSTIC PATHOLOGY MEDICAL GROUP, INC's top NAICS codes and agencies

NAICS: 621511
New
International
In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717
Solicitation # Project_1717
Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.
Supply Chain Coordination Limited

POSTED

about 8 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 621511
New
Federal
Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)
Solicitation # 36C25227Q0071
The Department of Veterans Affairs is conducting market research via a sources sought synopsis to identify qualified providers for blood donor panel testing services at the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. This requirement, categorized under NAICS code 621511 for Medical Laboratories, involves a five year ordering period consisting of five one year priced periods starting March 1, 2027. The selected contractor must provide all labor, materials, and expertise to perform a variety of tests, including standard donor panels, Anti-CMV, Chagas Antibody, West Nile Virus, and Babesia DNA/RNA, with estimated annual quantities ranging from 15 to 6,200 tests per category. The contractor must adhere to strict regulatory standards from the FDA, AABB, CAP, TJC, OSHA, CDC, and Department of Defense. Key performance requirements include a 95 percent success rate for reporting results within 24 hours of specimen receipt, with confirmation testing completed within seven calendar days. The contractor is responsible for providing specimen shipment containers and maintaining all necessary certifications, including CLIA and FDA approvals. The government reserves the right to conduct physical inspections of the contractor's facilities. Interested parties must submit organizational details and tailored capability statements by November 3, 2026, to help the government determine if the contract will be a small business set-aside, sole sourced, or open for full competition.
252-NETWORK Contract Office 12 (36C252)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
SLED
FURNISHING AND DELIVERY OF TOXICOLOGY SERVICES
Solicitation # B-27-254
The County of Middlesex, through the Office of the Medical Examiner, is soliciting bids for the furnishing and delivery of toxicology services and ancillary laboratory studies. The scope of work includes providing screening and confirmation for various analytes, specifically postmortem toxicology panels for controlled substances, abuse and therapeutic substances, designer drugs, novel psychoactive substances, and synthetic cannabinoids, as well as respiratory virus panels. The contract is structured as an open-ended, purchase-as-needed agreement, with estimated quantities ranging from 30 to 700 tests per category. The contract will be awarded to the lowest responsible bidder, with the County reserving the right to award by individual item, total bid, or a combination thereof. Bidders must submit their proposals electronically via the Middlesex County Electronic Procurement Portal by November 13, 2026. Required documentation includes a bid sheet, price certification, non-collusion affidavit, corporate resolution, and a bidder submittal checklist. A business registration certificate is mandatory before the final award. Compliance requirements are extensive, including adherence to the Davis-Bacon Act, the Contract Work Hours and Safety Standards Act, HIPAA regulations for medical confidentiality, and various New Jersey state laws regarding equal employment opportunities. The contractor is responsible for all transportation charges, with delivery terms set as F.O.B. destination. Payment is processed monthly, with a standard payment term of sixty calendar days from the receipt of a properly executed invoice. Additionally, the contract is subject to the Middlesex County Qualified Business Enterprise Set-Aside Program to encourage diversity among minority, women, veteran, and small business enterprises.
Office of Purchasing

POSTED

5 days ago

DEADLINE

in 16 days
View Details